Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study.
Akagi K, Taniguchi H, Fukuda M, Yamazaki T, Ono S, Tomono H, Suyama T, Shimada M, Gyotoku H, Takemoto S, Yamaguchi H, Dotsu Y, Senju H, Soda H, Mizowaki T, Monzen Y, Ikeda T, Nagashima S, Tasaki Y, Nakamura D, Komiya K, Nakatomi K, Sasaki E, Hirakawa K, Mukae H.
Akagi K, et al. Among authors: tomono h.
Thorac Cancer. 2022 Aug;13(16):2404-2409. doi: 10.1111/1759-7714.14555. Epub 2022 Jul 8.
Thorac Cancer. 2022.
PMID: 35808894
Free PMC article.